Collagen is the wrinkle filler that provides skin a plumper and smoother appearance. These can help to delay the formation of fine lines, deep wrinkles, and lost volume. The collagen injections replenish skin’s natural collagen, and by supplementing skin’s natural collagen, injection helps in smooth facial lines and type of acne scars. These are animal and human derived. The collagen obtained from cow protein provides support and structure to skin, bones, ligaments, and other body parts.  Human bioengineered collagen products are available in addition to hyaluronic acid-containing fillers. These are commonly used in cosmetic plastic surgery procedures to correct skin appearance. These can also eliminate lumps formed in lips. Collagen fillers are also called fat injectable fillers/soft tissue augmentation. Collagen fillers are used in plastic cosmetic surgery by injecting collagen into the skin, in order to fill up the area being treated in patients. Dermal fillers such as collagen fillers have temporary cosmetic effect as these contain materials such as collagen which is absorbed by the body in a particular interval of time. The result of procedure is usually not permanent and touch up injections may be needed every 3-12 months. However, collagen injections can stimulate body’s own production of collagen, lengthening the time necessary between follow up injections. The long-term safety of any collagen filler injection is unproven. Improper collagen filler usage can lead to long term pain, infections, scarring, and permanent disfigurement. Fatal side effects like the blockage of a blood vessel by a clot or onset of a stroke can also occur.

Market Dynamics

Increasing launches of new products, and mergers, and acquisitions by key market players is expected to drive the global collagen filler market growth. For instance, on October 7, 2020, Allergan Aesthetics, an AbbVie company, a Ireland- based pharmaceutical company, announced that it had entered into an agreement with Luminera, a Israel-based aesthetics company with a portfolio and pipeline of dermal filler products. Under the terms of the agreement, Allergan Aesthetics will acquire Luminera's full dermal filler portfolio and R&D pipeline that will further enhance  Allergan Aesthetics' leading dermal filler portfolio with its JUVÉDERM collection of fillers.

Key features of the study:

• This report provides an in-depth analysis of the global collagen filler market and provides market size (US$ Million) and compound annual growth rate (CAGR) for the forecast period (2023–2030), considering 2022 as the base year
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
• It profiles key players in the global collagen filler market based on the following parameters–company highlights, products portfolio, key highlights, financial performance, and strategies
• Key companies covered as a part of this study include Allergan, Inc.,  Johnson & Johnson Private Limited , Collplant Holdings Ltd, Ortho Dermatologics, Inc., Suneva Medical, Inc., Merz Pharma GmbH & Co. KGaA, Surgical Specialties Corporation, Sinclair Pharma, Inamed GmbH, and Endo International plc
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
• Global collagen filler market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global collagen filler market

Detailed Segmentation:

• Global Collagen Filler Market, By Product Type:
  • Collagen with PMMA
  • Collagen without PMMA
• Global Collagen Filler Market, By Source:
  • Bovine
  • Porcine
  • Others
• Global Collagen Filler Market, By Application:
  • Face Rejuvenation
  • Wrinkles
  • Scar Treatment
  • Lip Treatment
  • Cellulite Reduction
  • Others
• Global Collagen Filler Market, By End User:
  • Hospital
  • Dermatology Clinics
  • Otheras
• Global Collagen Filler Market, By Region:
  • North America
    
    • U.S.
    • Canada
  • Latin America
    
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
  • Europe
    
    • Germany
    • U.K.
    • France
    • Italy
    • Spain
    • Russia
    • Rest of Europe
  • Asia Pacific
    
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
  • Middle East
    
    • GCC
    • Israel
    • Rest of Middle East
  • Africa
    
    • South Africa
    • Central Africa
    • North Africa
• Company Profiles
  • Allergan, Inc.
  • Johnson & Johnson Private Limited
  • Collplant Holdings Ltd
  • Ortho Dermatologics, Inc.
  • Suneva Medical, Inc.
  • Merz Pharma GmbH & Co. KGaA
  • Surgical Specialties Corporation
  • Sinclair Pharma
  • Inamed GmbH
  • Endo International plc.